1-Al M Tab
FDC Ltd - tablet - 10 S
Standard delivery
Distributor inventory
Glimepiride 2 mg + Metformin hydrochloride (SR) 500 mg tablets
Type 2 diabetes mellitus (adult) when diet and exercise alone or single-agent therapy do not provide adequate glycaemic control
Glimepiride is a sulfonylurea that stimulates insulin release from pancreatic beta cells and improves peripheral insulin sensitivity. Metformin reduces hepatic glucose production and improves insulin sensitivity, lowering intestinal glucose absorption. Together they help control fasting and post‑meal blood glucose.
Oral tablet. Take exactly as prescribed, usually once daily with the first main meal (or as advised). Swallow whole; do not crush/chew (SR metformin). Monitor blood glucose regularly; avoid skipping meals to reduce risk of hypoglycaemia.
Common side effects of Ziglim M 2 may include:
FDC Ltd - tablet - 10 S
Standard delivery
FDC Ltd - syrup - 30 ml
Standard delivery

FDC Ltd - 5 mg - 10 S
Standard delivery
FDC Ltd - syrup - 250 ml
Standard delivery

FDC Ltd - tablet - 15 S
Standard delivery

FDC Ltd - suspension - 60 ml
Standard delivery
FDC Ltd - tablet - 5 mg - 15 S
Standard delivery

FDC Ltd - tablet - 15 S
Standard delivery
Risk of hypoglycaemia (especially with missed meals, alcohol, excessive exercise or dose changes). Metformin may rarely cause lactic acidosis—risk increases with severe kidney impairment, dehydration, sepsis, hypoxia, liver disease or heavy alcohol intake. Check renal function before starting and periodically; not recommended in severe renal impairment. Temporarily stop metformin around iodinated contrast studies or major surgery as advised by doctor. Use caution in elderly and in patients with G6PD deficiency (risk of haemolysis) and in those with heart failure or conditions causing poor oxygenation.